These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24073461)

  • 41. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
    [No Abstract]   [Full Text] [Related]  

  • 42. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 43. Two decades of public health achievements in lymphatic filariasis (2000-2020): reflections, progress and future challenges.
    Malecela M; Gyapong J; Ramaiah KD; Molyneux D
    Int Health; 2020 Dec; 13(Suppl 1):S1-S2. PubMed ID: 33349873
    [No Abstract]   [Full Text] [Related]  

  • 44. Lymphatic filariasis in India: epidemiology and control measures.
    Raju K; Jambulingam P; Sabesan S; Vanamail P
    J Postgrad Med; 2010; 56(3):232-8. PubMed ID: 20739779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The programme to eliminate lymphatic filariasis in Orissa, India: the attitudes of some programme partners.
    Babu BV; Nath N
    Ann Trop Med Parasitol; 2004 Oct; 98(7):751-7. PubMed ID: 15509429
    [No Abstract]   [Full Text] [Related]  

  • 46. Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies.
    Prada JM; Stolk WA; Davis EL; Touloupou P; Sharma S; Muñoz J; Caja Rivera RM; Reimer LJ; Michael E; de Vlas SJ; Hollingsworth TD
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):261-268. PubMed ID: 33515454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Call to consolidate achievements for onchocerciasis and lymphatic filariasis control.
    Hoerauf A; Walter RD; Remme H; Lazdins J; Fleischer B
    Trends Parasitol; 2001 Dec; 17(12):566-7. PubMed ID: 11756020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Field application of PCR-based assays for monitoring Wuchereria bancrofti infection in Africa.
    Ramzy RM
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S55-9. PubMed ID: 12625918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of medicine donations in the global programme for the elimination of lymphatic filariasis.
    Williams T; Taylor R; Iwamoto M; Hida T; Gusovsky F
    Int Health; 2020 Dec; 13(Suppl 1):S39-S43. PubMed ID: 33349878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
    Ramaiah KD; Ottesen EA
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3319. PubMed ID: 25412180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).
    Turner HC; Ottesen EA; Bradley MH
    Parasit Vectors; 2022 May; 15(1):181. PubMed ID: 35643508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic tools for filariasis elimination programs.
    Weil GJ; Ramzy RM
    Trends Parasitol; 2007 Feb; 23(2):78-82. PubMed ID: 17174604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elimination of lymphatic filariasis in India.
    Sabesan S; Ravi R; Das PK
    Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
    [No Abstract]   [Full Text] [Related]  

  • 54. Preventive chemotherapy for helminth diseases: progress report, 2014.
    Wkly Epidemiol Rec; 2016 Feb; 91(8):93-103. PubMed ID: 26922823
    [No Abstract]   [Full Text] [Related]  

  • 55. Conclusions of the meeting of the Technical Advisory Group on the Global Elimination of Lymphatic Filariasis, November 2007.
    Wkly Epidemiol Rec; 2008 Sep; 83(37):341-7. PubMed ID: 18788147
    [No Abstract]   [Full Text] [Related]  

  • 56. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2002 Apr; 77(16):125-32. PubMed ID: 12004537
    [No Abstract]   [Full Text] [Related]  

  • 57. Meeting of the International Task Force for Disease Eradication, November 2016.
    Wkly Epidemiol Rec; 2017 Mar; 92(9-10):106-16. PubMed ID: 28262011
    [No Abstract]   [Full Text] [Related]  

  • 58. Global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2008 Sep; 83(37):333-41. PubMed ID: 18788146
    [No Abstract]   [Full Text] [Related]  

  • 59. Meeting of the International Task Force for Disease Eradication – November 2012.
    Wkly Epidemiol Rec; 2013 Feb; 88(7):75-80. PubMed ID: 23540049
    [No Abstract]   [Full Text] [Related]  

  • 60. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
    Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
    Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.